| GC15363-10mg |
|
1177501-39-1 |
|
0 |
C11H16N2O5 |
|
|
|
| GC15362-25mg |
|
— |
|
0 |
C29H34F3N5O11 |
|
|
|
| GC15362-5mg |
|
— |
|
0 |
C29H34F3N5O11 |
|
|
|
| GC15360-50mg |
|
150403-96-6 |
Methyl-L-NIO (hydrochloride)
|
0 |
C8H17N3O2 • HCl |
|
|
|
| GC15360-25mg |
|
150403-96-6 |
Methyl-L-NIO (hydrochloride)
|
0 |
C8H17N3O2 • HCl |
|
|
|
| GC15360-10mg |
|
150403-96-6 |
Methyl-L-NIO (hydrochloride)
|
0 |
C8H17N3O2 • HCl |
|
|
|
| GC15360-5mg |
|
150403-96-6 |
Methyl-L-NIO (hydrochloride)
|
0 |
C8H17N3O2 • HCl |
|
|
|
| GC15359-10mM (in 1mL DMSO) |
|
305350-87-2 |
|
0 |
C16H12F3N3S |
|
|
|
| GC15359-100mg |
|
305350-87-2 |
|
0 |
C16H12F3N3S |
|
|
|
| GC15359-25mg |
|
305350-87-2 |
|
0 |
C16H12F3N3S |
|
|
|
| GC15359-5mg |
|
305350-87-2 |
|
0 |
C16H12F3N3S |
|
|
|
| GC15358-50mg |
|
959151-50-9 |
|
0 |
C22H23N3O |
|
|
|
| GC15358-10mg |
|
959151-50-9 |
|
0 |
C22H23N3O |
|
|
|
| GC15358-5mg |
|
959151-50-9 |
|
0 |
C22H23N3O |
|
|
|
| GC15357-50mg |
|
880149-29-1 |
Bismuth Subcitrate Potassium
|
0 |
C12H10BiK5O14<sup+2</sup |
|
|
|
| GC15356-1mg |
|
148439-49-0 |
Prion Protein 106-126 (human)
|
0 |
C80H138N26O24S2 |
|
|
|
| GC15355-100mg |
|
1309371-03-6 |
2-Trifluoromethyl-2'-methoxychalcone
|
0 |
C17H13F3O2 |
|
|
|
| GC15355-50mg |
|
1309371-03-6 |
2-Trifluoromethyl-2'-methoxychalcone
|
0 |
C17H13F3O2 |
|
|
|
| GC15355-10mg |
|
1309371-03-6 |
2-Trifluoromethyl-2'-methoxychalcone
|
0 |
C17H13F3O2 |
|
|
|
| GC15355-5mg |
|
1309371-03-6 |
2-Trifluoromethyl-2'-methoxychalcone
|
0 |
C17H13F3O2 |
|
|
|
